Biopreservation Market

7500+ companies worldwide approach us every year for their revenue growth initiatives

Global top 2000 strategist rely on us for their growth strategies.

80% of fortune 2000 companies rely on our research to identify new revenue sources.

30000 High Growth Opportunities

95% renewal rate

KNOW MORE

Biopreservation Market Size, Share & Trends by Product (Media [Cryopreservation, Hypothermic]), Equipment (Freezers, Refrigerators, Incubators, Centrifuge, Accessories), Biospecimen (Tissues, Organs, Stem Cells), Application (Research, Therapeutic) - Global Forecast to 2029

FREE BROCHURE FREE SAMPLE REPORT

Report Code: BT 1305 May, 2024, by marketsandmarkets.com

Biopreservation Market Size, Share & Trends

The size of global biopreservation market in terms of revenue was estimated to be worth $4.4 billion in 2024 and is poised to reach $7.1 billion by 2029, growing at a CAGR of 9.8% from 2024 to 2029. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics.

The growth in this market is attributed to the increasing initiatives research and development and growth in demand for organ transplants and storage. However, stability and transport related issues could restrain the growth of this market.

Biopreservation Market Trends

Biopreservation Market

To know about the assumptions considered for the study, Request for Free Sample Report

Biopreservation Market

Biopreservation Market Dynamics

DRIVER: Growing healthcare expenditure

Innovative medical procedures such as organ transplants, stem cell therapy, and regenerative medicine will be on the rise with the increasing healthcare expenditure. These procedures require frequent preservation of biological samples such as tissues, cells, and organs, which will result in the increased demand for biopreservation products that can effectively retain the vitality of these materials while preserving. According to the American Medical Association (AMA), in 2022, the healthcare expenditure in the US increased by 4.1%, reaching USD 4.4 trillion or USD 13,493 per person. Similarly, Canada’s total health spending was expected to reach USD 344 billion (12% of GDP) in 2023, or USD 8,740 per Canadian.

RESTRAINT: High cost of advanced techniques

Biopreservation is of outmost importance in the storage of bio samples. This involves the specific use of media and equipment, such as freezers, refrigerators, or cryogenic and other expensive storage equipment. Because of the components involved, the media solutions for organs, as well as for cells and tissues, are expensive to produce. Equipment like liquid nitrogen storage systems and tanks, are a one-time investment for storage and transport in which huge capital is involved in the initial stages of establishing a biopreservation setup. For instance, Thermo Fisher Value Lab Upright freezers cost USD 3,510, TSX Universal ULT Freezer costs range from USD 11,600 to USD 89,400, VWR CryoPro Standard Auto-Fill Systems costs range from USD 30,766 to USD 54,341, VWR CryoPro AFX Auto-Fill Systems costs range from USD 20,847 to USD 23,762, and the MVE Fusion Series Freezers costs range from USD 51,295 to USD 62,528.

OPPORTUNITY: Growing demand for organ transplants and cell & gene therapy

Organs like heart or lung can be kept viable for transplantation for only six hours, pancreas or liver for 12 hours, and a kidney for less than 30 hours. Hence, to maintain a proper condition, it is very important to preserve these organs. The aim of the preservation is to ensure the optimal functionality of the organ after transplantation so that the damage during this time is minimal. Degenerative reactions take place when the organ is removed from the donor, this is because of the alteration of homeostasis of the organ; therefore, it is very crucial to properly preserve the organs. Moreover, the rise in the number of cell and gene therapy products in development will support the demand for biopreservation solutions to store and manage biological materials used in these therapies, which includes cells, tissues, and viral vectors. This is due to increasing investments in cell and gene therapy R&D which has led to the significant growth of the therapy pipeline, with more candidate therapies advancing into clinical trials and commercialization.

CHALLENGE: Storage and transportation logistics

Ensuring the viability and integrity of preserved biological materials is technically challenging. Issues such as ice crystal formation during freezing, contamination risks, and sample degradation over time pose significant hurdles. Maintaining consistent quality control standards is also resource intensive. Furthermore, biological samples often need to be transported at consistent low temperatures to prevent degradation. Any break in the cold chain can compromise sample viability.

Biopreservation Industry Ecosystem

Prominent companies in this market include well-established, financially stable manufacturers of Biopreservation. These companies have been operating in the market for several years and possess diversified state-of-the-art technologies, product portfolios, and strong global sales and marketing networks. Prominent companies in this market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), PHC Holdings Corporation (Japan), and Azenta, Inc. (US).

Biopreservation Market Ecosystem

In 2023, biopreservation equipment segment to observe the highest growth rate of the biopreservation industry, by product.

Based on product, the biopreservation market is segmented into media, equipment, and accessories. The biopreservation media segment accounted for the largest market share in 2023. This is attributed to the frequent and repeated purchase of media when compared to equipment, and the media reflects their versatility and importance in preserving biological samples for diverse purposes.

In 2023, research application segment to dominate the biopreservation industry, by application.

Based on the application, the biopreservation market is segmented into therapeutic applications, research applications, and other applications. The research applications segment accounted for the largest market share in 2023. The growing research investments in biomedical research, personalized medicine, cell-based research, drug discovery, and other related segments will drive the market during the forecast period.

In 2023, biobanks segment to dominate the biopreservation industry, by end user.

Based on the end user, the biopreservation market is segmented into biobanks, gene banks, hospitals, and other end users such as research institutes and universities, pharmaceutical companies, and contract research organizations. The biobanks segment accounted for the largest share of the market in 2023. Advances in biobanks, more number of investments by the government in the biobanking sector, and collaborative research activities are supporting the growth of this end-user segment.

In 2023, North America to dominate in biopreservation industry.

The global biopreservation market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC. North America is expected to dominate during the forecast period, primarily due to the growing availability of government funding for research activities and healthcare spending, the presence of major players in the US, and increased collaborations and partnerships between biobanks and research institutes.

Biopreservation Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The Biopreservation market is dominated by players such as Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), PHC Holdings Corporation (Japan), Azenta, Inc. (US), Sartorius AG (Germany), Avantor, Inc. (US), ThermoGenesis Holdings, Inc. (US), Bio-Techne Corporation (US), BioLife Solutions Inc. (US), and Cryoport Inc. (US).

Scope of the Biopreservation Industry

Report Metric	Details
Market Revenue in 2024	$4.4 billion
Projected Revenue by 2029	$7.1 billion
Revenue Rate	Poised to Grow at a CAGR of 9.8%
Market Driver	Growing healthcare expenditure
Market Opportunity	Growing demand for organ transplants and cell & gene therapy

This research report categorizes the biopreservation market to forecast revenue and analyze trends in each of the following submarkets:

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa
GCC

By Product

Biopreservation Media
Biopreservation Equipment
Biopreservation Accessories

By Biospecimen

Human Tissue Samples
Organs
Stem Cell
Other Biospecimen

BY Application

Therapeutic Application
Research Application
Other Applications

By End User

Biobanks
Gene Banks
Hospitals
Other End Users

Recent Developments of Biopreservation Industry:

In 2024, Merck invested more than USD 321.7 million (EUR 300 million) into a new Bioprocessing Production Center in Daejeon, South Korea. The new site is the largest investment by Merck’s Life Science business sector in the Asia Pacific to date and demonstrates the company’s commitment to expanding its capacities in the fast-growing region. Merck expects the investment to create approximately 300 additional jobs by the end of 2028.
In 2024, Thermo Fisher Scientific introduced its newest line of high-performance, ultra-low temperature (ULT) freezers. With enhancements to performance, user experience, and energy efficiency, the Thermo Scientific TSX Universal Series ULT Freezers seamlessly adapt to scientists’ workflows across a variety of lab settings, marking a new era in performance, reliability, and sustainability.
In 2023, Avantor entered into an agreement with Tobin Scientific, a leading provider of biopharma cold chain, ambient storage, and transport & logistics services, to support end-to-end moves for US biopharma customers looking to relocate the labs, research facilities, and samples. This partnership will deal with the growing customer need for complex logistics solutions with temperature-specific requirements.

Frequently Asked Questions (FAQ):

What is the projected market revenue value of the global biopreservation market?

The global biopreservation market boasts a total revenue value of $7.1 billion by 2029.

What is the estimated growth rate (CAGR) of the global biopreservation market?

The global biopreservation market has an estimated compound annual growth rate (CAGR) of 9.8% and a revenue size in the region of $4.4 billion in 2024. .

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 42)

1.1 STUDY OBJECTIVES

1.2 MARKET DEFINITION

TABLE 1 INCLUSIONS AND EXCLUSIONS OF STUDY

1.3 STUDY SCOPE

1.3.1 MARKET SEGMENTATION

1.3.2 REGIONAL SCOPE

1.3.3 YEARS CONSIDERED

1.4 CURRENCY CONSIDERED

1.5 STAKEHOLDERS

1.6 LIMITATIONS

1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 48)

2.1 RESEARCH DATA

FIGURE 1 BIOPRESERVATION MARKET: RESEARCH DESIGN METHODOLOGY

2.1.1 SECONDARY DATA

2.1.1.1 Secondary sources

2.1.2 PRIMARY DATA

TABLE 2 KEY DATA FROM PRIMARY SOURCES

FIGURE 2 KEY INDUSTRY INSIGHTS

2.1.2.1 Breakdown of primary interviews

FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS

FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION

FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION

2.2 MARKET SIZE ESTIMATION

2.2.1 TOTAL MARKET SIZE: BIOPRESERVATION INDUSTRY

2.2.1.1 Approach 1: Bottom-up approach

FIGURE 6 BOTTOM-UP APPROACH: REVENUE-BASED APPROACH

2.2.1.2 Approach 2: Number of biopreservation equipment in biobanks

2.2.1.3 Approach 3: Secondary data and primary interviews

2.2.1.4 Growth forecast

2.2.1.5 CAGR projections

FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS

2.2.2 TOP-DOWN APPROACH

FIGURE 8 MARKET: TOP-DOWN APPROACH

2.3 MARKET BREAKDOWN AND DATA TRIANGULATION

FIGURE 9 DATA TRIANGULATION METHODOLOGY

2.4 MARKET SHARE ANALYSIS

2.5 STUDY ASSUMPTIONS

2.6 RISK ASSESSMENT

2.7 IMPACT OF RECESSION

3 EXECUTIVE SUMMARY (Page No. - 60)

FIGURE 10 BIOPRESERVATION MARKET, BY PRODUCT, 2024 VS. 2029 (USD BILLION)

FIGURE 11 BIOPRESERVATION INDUSTRY, BY BIOSPECIMEN, 2024 VS. 2029 (USD BILLION)

FIGURE 12 MARKET, BY APPLICATION, 2024 VS. 2029 (USD BILLION)

FIGURE 13 BIOPRESERVATION INDUSTRY, BY END USER, 2024 VS. 2029 (USD BILLION)

FIGURE 14 GEOGRAPHICAL SNAPSHOT OF MARKET

4 PREMIUM INSIGHTS (Page No. - 64)

4.1 BIOPRESERVATION MARKET OVERVIEW

FIGURE 15 RISING INVESTMENTS IN REGENERATIVE MEDICINE RESEARCH TO DRIVE MARKET

4.2 ASIA PACIFIC: BIOPRESERVATION INDUSTRY, BY BIOSPECIMEN AND COUNTRY (2023)

FIGURE 16 HUMAN TISSUE SAMPLES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2023

4.3 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD

4.4 MARKET: REGIONAL MIX

FIGURE 18 ASIA PACIFIC MARKET TO WITNESS HIGHEST GROWTH FROM 2024 TO 2029

4.5 MARKET: DEVELOPED VS. DEVELOPING MARKETS

FIGURE 19 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 68)

5.1 INTRODUCTION

5.2 MARKET DYNAMICS

FIGURE 20 BIOPRESERVATION MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

5.2.1 DRIVERS

5.2.1.1 Growing healthcare expenditure

5.2.1.2 Increasing R&D investments

5.2.1.3 Advances in biobanking and growing trend of conserving cord blood stem cells of newborns

5.2.1.4 Rising investments in regenerative medicine research

5.2.1.5 Increasing demand for personalized medicine

FIGURE 21 PERCENTAGE OF FDA-APPROVED PERSONALIZED MEDICINES (2015–2022)

5.2.2 RESTRAINTS

5.2.2.1 High cost of advanced techniques

5.2.2.2 Stability issues due to tissue injury during freezing and thawing

5.2.2.3 Issues related to biospecimen sample management

5.2.3 OPPORTUNITIES

5.2.3.1 Asia offers significant growth opportunities

5.2.3.2 Rising demand for organ transplants and cell & gene therapy

5.2.4 CHALLENGES

5.2.4.1 Increasing demand for room temperature storage technologies

5.2.4.2 Storage and transportation logistics

5.3 PRICING ANALYSIS

TABLE 3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT

TABLE 4 AVERAGE SELLING PRICE TREND, BY REGION

5.4 PATENT ANALYSIS

FIGURE 22 PATENT ANALYSIS FOR CRYOGENIC STORAGE SYSTEMS (JANUARY 2014–DECEMBER 2023)

5.5 VALUE CHAIN ANALYSIS

FIGURE 23 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING & ASSEMBLY PHASES

5.6 SUPPLY CHAIN ANALYSIS

FIGURE 24 BIOPRESERVATION INDUSTRY: SUPPLY CHAIN ANALYSIS

5.7 ECOSYSTEM ANALYSIS

FIGURE 25 MARKET: ECOSYSTEM ANALYSIS

5.7.1 MARKET: ROLE IN ECOSYSTEM

FIGURE 26 KEY PLAYERS IN MARKET

5.8 PORTER’S FIVE FORCES ANALYSIS

TABLE 5 MARKET: PORTER’S FIVE FORCES ANALYSIS

FIGURE 27 MARKET: PORTER’S FIVE FORCES ANALYSIS

5.8.1 THREAT OF NEW ENTRANTS

5.8.2 THREAT OF SUBSTITUTES

5.8.3 BARGAINING POWER OF SUPPLIERS

5.8.4 BARGAINING POWER OF BUYERS

5.8.5 INTENSITY OF COMPETITIVE RIVALRY

5.9 REGULATORY ANALYSIS

TABLE 6 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 7 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 8 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 9 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 10 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

5.9.1 US

5.9.2 EUROPEAN UNION

5.10 TRADE ANALYSIS

TABLE 11 EXPORT DATA FOR HS CODE 841869, BY COUNTRY, 2019–2023 (USD MILLION)

TABLE 12 IMPORT DATA FOR HS CODE 841869, BY COUNTRY, 2019–2023 (USD MILLION)

5.11 TECHNOLOGY ANALYSIS

5.11.1 KEY TECHNOLOGIES

5.11.1.1 Cryopreservation

5.11.1.2 Hypothermic preservation

5.11.2 ADJACENT TECHNOLOGIES

5.11.2.1 Normothermic machine perfusion

5.12 KEY CONFERENCES AND EVENTS IN 2024–2025

TABLE 13 MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS

5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS

5.13.1 REVENUE SHIFT IN BIOPRESERVATION

5.14 KEY STAKEHOLDERS AND BUYING CRITERIA

5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS

FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOPRESERVATION PRODUCTS, BY END USER

TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BIOPRESERVATION PRODUCTS, BY END USER

5.14.2 BUYING CRITERIA

FIGURE 29 KEY BUYING CRITERIA FOR END USERS

TABLE 15 KEY BUYING CRITERIA, BY END USER

5.15 INVESTMENT AND FUNDING SCENARIO

FIGURE 30 MARKET: INVESTMENT & FUNDING SCENARIO

6 BIOPRESERVATION MARKET, BY PRODUCT (Page No. - 96)

6.1 INTRODUCTION

TABLE 16 BIOPRESERVATION INDUSTRY, BY PRODUCT, 2022–2029 (USD MILLION)

6.2 BIOPRESERVATION MEDIA

TABLE 17 BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 18 BIOPRESERVATION MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 19 NORTH AMERICA: BIOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 20 EUROPE: BIOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 21 ASIA PACIFIC: BIOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 22 LATIN AMERICA: BIOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.2.1 CRYOPRESERVATION MEDIA

6.2.1.1 Largest and fastest-growing segment of biopreservation media market

TABLE 23 CRYOPRESERVATION MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 24 NORTH AMERICA: CRYOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 25 EUROPE: CRYOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 26 ASIA PACIFIC: CRYOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 27 LATIN AMERICA: CRYOPRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.2.2 HYPOTHERMIC PRESERVATION MEDIA

6.2.2.1 Increase in organ transplants to support segment growth

TABLE 28 HYPOTHERMIC PRESERVATION MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 29 NORTH AMERICA: HYPOTHERMIC PRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 30 EUROPE: HYPOTHERMIC PRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 31 ASIA PACIFIC: HYPOTHERMIC PRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 32 LATIN AMERICA: HYPOTHERMIC PRESERVATION MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.3 BIOPRESERVATION EQUIPMENT

TABLE 33 BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 34 BIOPRESERVATION EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 35 NORTH AMERICA: BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 36 EUROPE: BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 37 ASIA PACIFIC: BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 38 LATIN AMERICA; BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.3.1 TEMPERATURE CONTROL SYSTEMS

TABLE 39 TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 40 TEMPERATURE CONTROL SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 41 NORTH AMERICA: TEMPERATURE CONTROL SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 42 EUROPE: TEMPERATURE CONTROL SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 43 ASIA PACIFIC: TEMPERATURE CONTROL SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 44 LATIN AMERICA: TEMPERATURE CONTROL SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.3.1.1 Freezers

6.3.1.1.1 Growing demand for advanced energy-efficient ultra-low-temperature freezers to propel market

TABLE 45 FREEZERS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 46 NORTH AMERICA: FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 47 EUROPE: FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 48 ASIA PACIFIC: FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 49 LATIN AMERICA: FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.3.1.2 Cryogenic storage systems

6.3.1.2.1 Used for storage of samples below -130°C

TABLE 50 CRYOGENIC STORAGE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 51 NORTH AMERICA: CRYOGENIC STORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 52 EUROPE: CRYOGENIC STORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 53 ASIA PACIFIC: CRYOGENIC STORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 54 LATIN AMERICA: CRYOGENIC STORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.3.1.3 Thawing equipment

6.3.1.3.1 Rapid thawing essential for ideal preservation of cells

TABLE 55 THAWING EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 56 NORTH AMERICA: THAWING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 57 EUROPE: THAWING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 58 ASIA PACIFIC: THAWING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 59 LATIN AMERICA: THAWING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.3.1.4 Refrigerators

6.3.1.4.1 Used for storage of samples at constant temperature

TABLE 60 REFRIGERATORS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 61 NORTH AMERICA: REFRIGERATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 62 EUROPE: REFRIGERATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 63 ASIA PACIFIC: REFRIGERATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 64 LATIN AMERICA: REFRIGERATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.3.2 ALARM MONITORING SYSTEMS

6.3.2.1 Help scrutinize proper functioning of biopreservation equipment

TABLE 65 ALARM MONITORING SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 66 NORTH AMERICA: ALARM MONITORING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 67 EUROPE: ALARM MONITORING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 68 ASIA PACIFIC: ALARM MONITORING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 69 LATIN AMERICA: ALARM MONITORING SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.3.3 INCUBATORS

6.3.3.1 Help maintain favorable environment for cell growth

TABLE 70 INCUBATORS MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 71 NORTH AMERICA: INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 72 EUROPE: INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 73 ASIA PACIFIC: INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 74 LATIN AMERICA: INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.3.4 CENTRIFUGES

6.3.4.1 Used for isolating and separating suspensions and immiscible liquids

TABLE 75 CENTRIFUGES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 76 NORTH AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 77 EUROPE: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 78 ASIA PACIFIC: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 79 LATIN AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.3.5 OTHER BIOPRESERVATION EQUIPMENT

TABLE 80 OTHER BIOPRESERVATION EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 81 NORTH AMERICA: OTHER BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 82 EUROPE: OTHER BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 83 ASIA PACIFIC: OTHER BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 84 LATIN AMERICA: OTHER BIOPRESERVATION EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

6.4 BIOPRESERVATION ACCESSORIES

6.4.1 INDISPENSABLE AND INTEGRAL COMPONENTS OF BIOPRESERVATION PROCEDURES

TABLE 85 BIOPRESERVATION ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)

TABLE 86 NORTH AMERICA: BIOPRESERVATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 87 EUROPE: BIOPRESERVATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 88 ASIA PACIFIC: BIOPRESERVATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 89 LATIN AMERICA: BIOPRESERVATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

7 BIOPRESERVATION MARKET, BY BIOSPECIMEN (Page No. - 129)

7.1 INTRODUCTION

TABLE 90 BIOPRESERVATION INDUSTRY, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

7.2 HUMAN TISSUE SAMPLES

7.2.1 GROWTH IN R&D SPENDING FOR LIFE SCIENCE RESEARCH TO DRIVE MARKET

TABLE 91 BIOPRESERVATION MARKET FOR HUMAN TISSUE SAMPLES, BY REGION, 2022–2029 (USD MILLION)

TABLE 92 NORTH AMERICA: MARKET FOR HUMAN TISSUE SAMPLES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 93 EUROPE: MARKET FOR HUMAN TISSUE SAMPLES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 94 ASIA PACIFIC: MARKET FOR HUMAN TISSUE SAMPLES, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 95 LATIN AMERICA: MARKET FOR HUMAN TISSUE SAMPLES, BY COUNTRY, 2022–2029 (USD MILLION)

7.3 ORGANS

7.3.1 INCREASING NUMBER OF ORGAN TRANSPLANTS TO DRIVE MARKET GROWTH

FIGURE 31 ORGAN TRANSPLANTATION PROCEDURES PERFORMED WORLDWIDE, BY ORGAN TYPE (2024)

TABLE 96 BIOPRESERVATION MAINDUSTRY RKET FOR ORGANS, BY REGION, 2022–2029 (USD MILLION)

TABLE 97 NORTH AMERICA: MARKET FOR ORGANS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 98 EUROPE: MARKET FOR ORGANS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 99 ASIA PACIFIC: MARKET FOR ORGANS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 100 LATIN AMERICA: MARKET FOR ORGANS, BY COUNTRY, 2022–2029 (USD MILLION)

7.4 STEM CELLS

7.4.1 ADVANCEMENTS IN STEM CELL THERAPY TO PROPEL MARKET

TABLE 101 BIOPRESERVATION MARKET FOR STEM CELLS, BY REGION, 2022–2029 (USD MILLION)

TABLE 102 NORTH AMERICA: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 103 EUROPE: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 104 ASIA PACIFIC: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 105 LATIN AMERICA: MARKET FOR STEM CELLS, BY COUNTRY, 2022–2029 (USD MILLION)

7.5 OTHER BIOSPECIMENS

TABLE 106 BIOPRESERVATION INDUSTRY FOR OTHER BIOSPECIMENS, BY REGION, 2022–2029 (USD MILLION)

TABLE 107 NORTH AMERICA: MARKET FOR OTHER BIOSPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 108 EUROPE: MARKET FOR OTHER BIOSPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 109 ASIA PACIFIC: MARKET FOR OTHER BIOSPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 110 LATIN AMERICA: MARKET FOR OTHER BIOSPECIMENS, BY COUNTRY, 2022–2029 (USD MILLION)

8 BIOPRESERVATION MARKET, BY APPLICATION (Page No. - 140)

8.1 INTRODUCTION

TABLE 111 BIOPRESERVATION INDUSTRY, BY APPLICATION, 2022–2029 (USD MILLION)

8.2 RESEARCH APPLICATIONS

8.2.1 GOVERNMENT INITIATIVES TO SUPPORT MARKET GROWTH

TABLE 112 BIOPRESERVATION MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)

TABLE 113 NORTH AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 114 EUROPE: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 115 ASIA PACIFIC: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 116 LATIN AMERICA: MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

8.3 THERAPEUTIC APPLICATIONS

8.3.1 INCREASING UTILIZATION OF STEM CELLS FOR TREATMENT OF DISEASES TO DRIVE MARKET

TABLE 117 BIOPRESERVATION INDUSTRY FOR THERAPEUTIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)

TABLE 118 NORTH AMERICA: MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 119 EUROPE: MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 120 ASIA PACIFIC: MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 121 LATIN AMERICA: MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

8.4 OTHER APPLICATIONS

TABLE 122 BIOPRESERVATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)

TABLE 123 NORTH AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 124 EUROPE: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 125 ASIA PACIFIC: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 126 LATIN AMERICA: MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)

9 BIOPRESERVATION MARKET, BY END USER (Page No. - 149)

9.1 INTRODUCTION

TABLE 127 BIOPRESERVATION INDUSTRY, BY END USER, 2022–2029 (USD MILLION)

9.2 BIOBANKS

9.2.1 INCREASING RESEARCH IN FIELD OF PERSONALIZED MEDICINE TO DRIVE MARKET

TABLE 128 BIOPRESERVATION MARKET FOR BIOBANKS, BY REGION, 2022–2029 (USD MILLION)

TABLE 129 NORTH AMERICA: MARKET FOR BIOBANKS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 130 EUROPE: MARKET FOR BIOBANKS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 131 ASIA PACIFIC: MARKET FOR BIOBANKS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 132 LATIN AMERICA: MARKET FOR BIOBANKS, BY COUNTRY, 2022–2029 (USD MILLION)

9.3 GENE BANKS

9.3.1 GROWING GENE THERAPY APPROVALS TO SUPPORT MARKET GROWTH

TABLE 133 BIOPRESERVATION INDUSTRY FOR GENE BANKS, BY REGION, 2022–2029 (USD MILLION)

TABLE 134 NORTH AMERICA: MARKET FOR GENE BANKS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 135 EUROPE: MARKET FOR GENE BANKS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 136 ASIA PACIFIC: MARKET FOR GENE BANKS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 137 LATIN AMERICA: MARKET FOR GENE BANKS, BY COUNTRY, 2022–2029 (USD MILLION)

9.4 HOSPITALS

9.4.1 GROWING NUMBER OF ORGAN TRANSPLANT PROCEDURES TO PROPEL MARKET

TABLE 138 BIOPRESERVATION MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION)

TABLE 139 NORTH AMERICA: MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 140 EUROPE: MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 141 ASIA PACIFIC: MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 142 LATIN AMERICA: MARKET FOR HOSPITALS, BY COUNTRY, 2022–2029 (USD MILLION)

9.5 OTHER END USERS

TABLE 143 BIOPRESERVATION INDUSTRY FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)

TABLE 144 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 145 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 146 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 147 LATIN AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)

10 BIOPRESERVATION MARKET, BY REGION (Page No. - 161)

10.1 INTRODUCTION

TABLE 148 BIOPRESERVATION INDUSTRY, BY REGION, 2022–2029 (USD MILLION)

10.2 NORTH AMERICA

FIGURE 32 NORTH AMERICA: BIOPRESERVATION MARKET SNAPSHOT

TABLE 149 NORTH AMERICA: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 150 NORTH AMERICA: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 151 NORTH AMERICA: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 152 NORTH AMERICA: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 153 NORTH AMERICA: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 154 NORTH AMERICA: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 155 NORTH AMERICA: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 156 NORTH AMERICA: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.2.1 RECESSION IMPACT: NORTH AMERICA

10.2.2 US

10.2.2.1 High incidence of chronic and genetic diseases to drive market

TABLE 157 US: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 158 US: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 159 US: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 160 US: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 161 US: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 162 US: MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 163 US: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

TABLE 164 US: BIOPRESERVATION MARKET, BY TRANSPLANT TYPE, 2022–2029 (THOUSAND)

10.2.3 CANADA

10.2.3.1 Government funding for research and innovation to support market growth

TABLE 165 CANADA: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 166 CANADA: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 167 CANADA: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 168 CANADA: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 169 CANADA: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 170 CANADA: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 171 CANADA: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.3 EUROPE

10.3.1 EUROPE: RECESSION IMPACT

TABLE 172 EUROPE: BIOPRESERVATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 173 EUROPE: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 174 EUROPE: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 175 EUROPE: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 176 EUROPE: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 177 EUROPE: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 178 EUROPE: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 179 EUROPE: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.3.2 GERMANY

10.3.2.1 Presence of advanced infrastructure to propel market

TABLE 180 GERMANY: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 181 GERMANY: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 182 GERMANY: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 183 GERMANY: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 184 GERMANY: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 185 GERMANY: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 186 GERMANY: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.3.3 UK

10.3.3.1 High R&D expenditure to drive market

TABLE 187 UK: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 188 UK: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 189 UK: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 190 UK: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 191 UK: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 192 UK: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 193 UK: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.3.4 FRANCE

10.3.4.1 Advances in research activities to support market growth

TABLE 194 FRANCE: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 195 FRANCE: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 196 FRANCE: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 197 FRANCE: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 198 FRANCE: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 199 FRANCE: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 200 FRANCE: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.3.5 ITALY

10.3.5.1 Increase in life sciences research projects to drive market

TABLE 201 ITALY: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 202 ITALY: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 203 ITALY: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 204 ITALY: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 205 ITALY: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 206 ITALY: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 207 ITALY: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.3.6 SPAIN

10.3.6.1 Government initiatives for development of healthcare system to support market growth

TABLE 208 SPAIN: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 209 SPAIN: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 210 SPAIN: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 211 SPAIN: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 212 SPAIN: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 213 SPAIN: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 214 SPAIN: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.3.7 REST OF EUROPE

TABLE 215 REST OF EUROPE: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 216 REST OF EUROPE: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 217 REST OF EUROPE: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 218 REST OF EUROPE: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 219 REST OF EUROPE: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 220 REST OF EUROPE: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 221 REST OF EUROPE: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.4 ASIA PACIFIC

10.4.1 ASIA PACIFIC: RECESSION IMPACT

FIGURE 33 ASIA PACIFIC: BIOPRESERVATION MARKET SNAPSHOT

TABLE 222 ASIA PACIFIC: MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 223 ASIA PACIFIC: MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 224 ASIA PACIFIC: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 225 ASIA PACIFIC: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 226 ASIA PACIFIC: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 227 ASIA PACIFIC: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 228 ASIA PACIFIC: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 229 ASIA PACIFIC: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.4.2 CHINA

10.4.2.1 High research and development expenditure to propel market

TABLE 230 CHINA: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 231 CHINA: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 232 CHINA: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 233 CHINA: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 234 CHINA: BIOPRESERVATION MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 235 CHINA: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 236 CHINA: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.4.3 JAPAN

10.4.3.1 Government initiatives to support market growth

TABLE 237 JAPAN: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 238 JAPAN: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 239 JAPAN: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 240 JAPAN: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 241 JAPAN: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 242 JAPAN: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 243 JAPAN: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.4.4 INDIA

10.4.4.1 Increasing investments in research activities to support market growth

TABLE 244 INDIA: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 245 INDIA: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 246 INDIA: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 247 INDIA: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 248 INDIA: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 249 INDIA: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 250 INDIA: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.4.5 REST OF ASIA PACIFIC

TABLE 251 REST OF ASIA PACIFIC: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 252 REST OF ASIA PACIFIC: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 253 REST OF ASIA PACIFIC: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 254 REST OF ASIA PACIFIC: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 255 REST OF ASIA PACIFIC: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 256 REST OF ASIA PACIFIC: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 257 REST OF ASIA PACIFIC: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.5 LATIN AMERICA

10.5.1 LATIN AMERICA: RECESSION IMPACT

TABLE 258 LATIN AMERICA: BIOPRESERVATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION)

TABLE 259 LATIN AMERICA: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 260 LATIN AMERICA: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 261 LATIN AMERICA: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 262 LATIN AMERICA: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 263 LATIN AMERICA: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 264 LATIN AMERICA: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 265 LATIN AMERICA: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.5.2 BRAZIL

10.5.2.1 High investments in pharmaceutical R&D to propel market

TABLE 266 BRAZIL: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 267 BRAZIL: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 268 BRAZIL: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 269 BRAZIL: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 270 BRAZIL: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 271 BRAZIL: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 272 BRAZIL: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.5.3 MEXICO

10.5.3.1 Growth in pharmaceutical industry to support market growth

TABLE 273 MEXICO: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 274 MEXICO: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 275 MEXICO: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 276 MEXICO: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 277 MEXICO: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 278 MEXICO: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 279 MEXICO: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.5.4 REST OF LATIN AMERICA

TABLE 280 REST OF LATIN AMERICA: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 281 REST OF LATIN AMERICA: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 282 REST OF LATIN AMERICA: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 283 REST OF LATIN AMERICA: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 284 REST OF LATIN AMERICA: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 285 REST OF LATIN AMERICA: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 286 REST OF LATIN AMERICA: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.6 MIDDLE EAST & AFRICA

10.6.1 GROWING INVESTMENTS IN STEM CELL RESEARCH TO DRIVE MARKET

10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

TABLE 287 MIDDLE EAST & AFRICA: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 288 MIDDLE EAST & AFRICA: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 289 MIDDLE EAST & AFRICA: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 290 MIDDLE EAST & AFRICA: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 291 MIDDLE EAST & AFRICA: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 292 MIDDLE EAST & AFRICA: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 293 MIDDLE EAST & AFRICA: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

10.7 GCC COUNTRIES

10.7.1 INCREASING HEALTHCARE SPENDING TO DRIVE MARKET

10.7.2 GCC COUNTRIES: RECESSION IMPACT

TABLE 294 GCC COUNTRIES: BIOPRESERVATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION)

TABLE 295 GCC COUNTRIES: BIOPRESERVATION MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 296 GCC COUNTRIES: BIOPRESERVATION EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 297 GCC COUNTRIES: TEMPERATURE CONTROL SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)

TABLE 298 GCC COUNTRIES: MARKET, BY BIOSPECIMEN, 2022–2029 (USD MILLION)

TABLE 299 GCC COUNTRIES: BIOPRESERVATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION)

TABLE 300 GCC COUNTRIES: BIOPRESERVATION MARKET, BY END USER, 2022–2029 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 232)

11.1 OVERVIEW

11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN

TABLE 301 OVERVIEW OF STRATEGIES ADOPTED BY KEY BIOPRESERVATION COMPANIES

11.3 REVENUE ANALYSIS

FIGURE 34 REVENUE ANALYSIS FOR KEY COMPANIES IN BIOPRESERVATION MARKET, 2019–2023 (USD MILLION)

11.4 MARKET SHARE ANALYSIS

FIGURE 35 BIOPRESERVATION INDUSTRY SHARE ANALYSIS, BY KEY PLAYER (2023)

TABLE 302 BIOPRESERVATION INDUSTRY: DEGREE OF COMPETITION

11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023

11.5.1 STARS

11.5.2 EMERGING LEADERS

11.5.3 PERVASIVE PLAYERS

11.5.4 PARTICIPANTS

FIGURE 36 BIOPRESERVATION INDUSTRY: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023

11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023

11.5.5.1 Company footprint

FIGURE 37 BIOPRESERVATION INDUSTRY: COMPANY FOOTPRINT

11.5.5.2 Regional footprint

TABLE 303 BIOPRESERVATION INDUSTRY: REGIONAL FOOTPRINT

11.5.5.3 Product footprint

TABLE 304 BIOPRESERVATION INDUSTRY: PRODUCT FOOTPRINT

11.5.5.4 Biospecimen footprint

TABLE 305 BIOPRESERVATION INDUSTRY: BIOSPECIMEN FOOTPRINT

11.5.5.5 Application footprint

TABLE 306 BIOPRESERVATION INDUSTRY: APPLICATION FOOTPRINT

11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023

11.6.1 PROGRESSIVE COMPANIES

11.6.2 STARTING BLOCKS

11.6.3 RESPONSIVE COMPANIES

11.6.4 DYNAMIC COMPANIES

FIGURE 38 BIOPRESERVATION INDUSTRY: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023

11.6.5 COMPETITIVE BENCHMARKING

TABLE 307 BIOPRESERVATION INDUSTRY: DETAILED LIST OF KEY STARTUPS/SMES

11.6.6 COMPANY FOOTPRINT: STARTUPS/SMES, 2023

11.6.6.1 Company footprint

TABLE 308 BIOPRESERVATION INDUSTRY: COMPANY FOOTPRINT (STARTUPS/SMES)

11.6.6.2 Product footprint

TABLE 309 BIOPRESERVATION INDUSTRY: PRODUCT FOOTPRINT (STARTUPS/SMES)

11.6.6.3 Regional footprint

TABLE 310 BIOPRESERVATION INDUSTRY: REGIONAL FOOTPRINT (STARTUPS/SMES)

11.7 VALUATION & FINANCIAL METRICS

FIGURE 39 EV/EBITDA OF KEY VENDORS

FIGURE 40 EV/REVENUE OF KEY VENDORS

FIGURE 41 BETA (5 YEARS) OF KEY VENDORS

FIGURE 42 1-YEAR PRICE TOTAL RETURN OF KEY VENDORS

11.8 BRAND/PRODUCT COMPARISON

FIGURE 43 BIOPRESERVATION INDUSTRY: BRAND/PRODUCT COMPARATIVE ANALYSIS

11.9 COMPETITIVE SCENARIO

11.9.1 PRODUCT LAUNCHES

TABLE 311 BIOPRESERVATION INDUSTRY: PRODUCT LAUNCHES, JANUARY 2021– APRIL 2024

11.9.2 DEALS

TABLE 312 BIOPRESERVATION INDUSTRY: DEALS, JANUARY 2021– APRIL 2024

11.9.3 EXPANSIONS

TABLE 313 BIOPRESERVATION INDUSTRY: EXPANSIONS, JANUARY 2021– APRIL 2024

12 COMPANY PROFILES (Page No. - 251)

(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *

12.1 KEY PLAYERS

12.1.1 THERMO FISHER SCIENTIFIC INC.

TABLE 314 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW

FIGURE 44 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)

TABLE 315 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED

TABLE 316 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES

12.1.2 MERCK KGAA

TABLE 317 MERCK KGAA: BUSINESS OVERVIEW

FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT (2023)

TABLE 318 MERCK KGAA: PRODUCTS OFFERED

TABLE 319 MERCK KGAA: EXPANSIONS

12.1.3 PHC HOLDINGS CORPORATION

TABLE 320 PHC HOLDINGS CORPORATION: BUSINESS OVERVIEW

FIGURE 46 PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT (2023)

TABLE 321 EXCHANGE RATES (UTILIZED FOR CONVERSION OF YEN TO USD)

TABLE 322 PHC HOLDINGS CORPORATION: PRODUCTS OFFERED

TABLE 323 PRODUCT LAUNCHES

12.1.4 AZENTA, INC.

TABLE 324 AZENTA, INC.: BUSINESS OVERVIEW

FIGURE 47 AZENTA, INC.: COMPANY SNAPSHOT (2023)

TABLE 325 AZENTA, INC.: PRODUCTS OFFERED

TABLE 326 AZENTA, INC.: PRODUCT LAUNCHES

TABLE 327 AZENTA, INC.: DEALS

12.1.5 AVANTOR, INC.

TABLE 328 AVANTOR, INC.: BUSINESS OVERVIEW

FIGURE 48 AVANTOR, INC.: COMPANY SNAPSHOT (2023)

TABLE 329 AVANTOR, INC.: PRODUCTS OFFERED

TABLE 330 AVANTOR, INC.: DEALS

12.1.6 SARTORIUS AG

TABLE 331 SARTORIUS AG: BUSINESS OVERVIEW

FIGURE 49 SARTORIUS AG: COMPANY SNAPSHOT (2023)

TABLE 332 EXCHANGE RATES (UTILIZED FOR CONVERSION OF EUR TO USD)

TABLE 333 SARTORIUS AG: PRODUCTS OFFERED

12.1.7 THERMOGENESIS HOLDINGS, INC.

TABLE 334 THERMOGENESIS HOLDINGS, INC.: BUSINESS OVERVIEW

FIGURE 50 THERMOGENESIS HOLDINGS, INC.: COMPANY SNAPSHOT (2023)

TABLE 335 THERMOGENESIS HOLDINGS, INC.: PRODUCTS OFFERED

TABLE 336 THERMOGENESIS HOLDINGS, INC.: EXPANSIONS

12.1.8 BIO-TECHNE CORPORATION

TABLE 337 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW

FIGURE 51 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2023)

TABLE 338 BIO-TECHNE CORPORATION: PRODUCTS OFFERED

12.1.9 BIOLIFE SOLUTIONS INC.

TABLE 339 BIOLIFE SOLUTIONS, INC.: BUSINESS OVERVIEW

FIGURE 52 BIOLIFE SOLUTIONS, INC.: COMPANY SNAPSHOT (2023)

TABLE 340 BIOLIFE SOLUTIONS, INC.: PRODUCTS OFFERED

TABLE 341 BIOLIFE SOLUTIONS, INC.: PRODUCT LAUNCHES

TABLE 342 BIOLIFE SOLUTIONS, INC.: DEALS

12.1.10 CRYOPORT INC.

TABLE 343 CRYOPORT INC.: BUSINESS OVERVIEW

FIGURE 53 CRYOPORT INC.: COMPANY SNAPSHOT (2023)

TABLE 344 CRYOPORT INC.: PRODUCTS OFFERED

TABLE 345 CRYOPORT INC.: DEALS

12.1.11 SO-LOW ENVIRONMENTAL EQUIPMENT CO.

TABLE 346 SO-LOW ENVIRONMENTAL EQUIPMENT CO.: BUSINESS OVERVIEW

TABLE 347 SO-LOW ENVIRONMENTAL EQUIPMENT CO.: PRODUCTS OFFERED

12.2 OTHER PLAYERS

12.2.1 SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.

TABLE 348 SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW

12.2.2 HELMER SCIENTIFIC INC.

TABLE 349 HELMER SCIENTIFIC INC.: COMPANY OVERVIEW

12.2.3 ARCTIKO

TABLE 350 ARCTIKO: COMPANY OVERVIEW

12.2.4 NIPPON GENETICS EUROPE

TABLE 351 NIPPON GENETICS EUROPE: COMPANY OVERVIEW

12.2.5 STEMCELL TECHNOLOGIES, INC.

TABLE 352 STEMCELL TECHNOLOGIES, INC.: COMPANY OVERVIEW

12.2.6 AMSBIO

TABLE 353 AMSBIO: COMPANY OVERVIEW

12.2.7 OPS DIAGNOSTICS

TABLE 354 OPS DIAGNOSTICS: COMPANY OVERVIEW

12.2.8 ASKION GMBH

TABLE 355 ASKION GMBH: COMPANY OVERVIEW

12.2.9 DOHMEYER

TABLE 356 DOHMEYER: COMPANY OVERVIEW

12.2.10 X-THERMA, INC.

TABLE 357 X-THERMA, INC.: COMPANY OVERVIEW

12.2.11 IC BIOMEDICAL, LLC

TABLE 358 IC BIOMEDICAL, LLC: COMPANY OVERVIEW

12.2.12 TAIYO NIPPON SANSO CORPORATION

TABLE 359 TAIYO NIPPON SANSO CORPORATION: COMPANY OVERVIEW

12.2.13 FROILABO

TABLE 360 FROILABO: COMPANY OVERVIEW

12.2.14 CELLBIOS HEALTHCARE & LIFESCIENCES PVT. LTD.

TABLE 361 CELLBIOS HEALTHCARE & LIFESCIENCES PVT. LTD.: COMPANY OVERVIEW

*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 307)

13.1 DISCUSSION GUIDE

13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

13.3 CUSTOMIZATION OPTIONS

13.4 RELATED REPORTS

13.5 AUTHOR DETAILS

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are:

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants:

Biopreservation Market Size, and Share

Note 1: *Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

Product mapping of various manufacturers for each type of Biopreservation market at the regional and country-level
Relative adoption pattern of each Biopreservation market among key application segments at the regional and/or country-level
Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level.
Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level

Global Biopreservation Market Size: Top Down Approach

Biopreservation Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Biopreservation Market Size: Bottom-Up Approach

Biopreservation Market Size, and Share

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.

Market Definition

Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.

Key Stakeholders

Senior Management
Finance/Procurement Department
Doctors/HCPs
Researchers
Lab Managers/Technicians
End Users/Operators

Report Objectives

To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
To define, describe, segment, and forecast the Biopreservation market by product, biospecimen, application, end user, and region.
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Biopreservation market
To forecast the size of the Biopreservation market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC.
To profile key players in the Biopreservation market and comprehensively analyze their core competencies and market shares
To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Biopreservation market.
To benchmark players within the Biopreservation market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

Additional country-level analysis of the Biopreservation market
Profiling of additional market players (up to 5)

Product Analysis

Product matrix, which provides a detailed comparison of the product portfolio of each company in the Biopreservation Market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.